Logo
Logo
Log inSign up
Logo

Tools

AI Concept MapsAI Mind MapsAI Study NotesAI FlashcardsAI Quizzes

Resources

BlogTemplate

Info

PricingFAQTeam

info@algoreducation.com

Corso Castelfidardo 30A, Torino (TO), Italy

Algor Lab S.r.l. - Startup Innovativa - P.IVA IT12537010014

Privacy PolicyCookie PolicyTerms and Conditions

The Sodium-Potassium Pump: Essential Cellular Mechanism

The sodium-potassium pump is a crucial enzyme that regulates ion gradients across cell membranes, using ATP to transport Na+ and K+ ions. Its activity is modulated by endogenous factors like cAMP and exogenous substances such as hormones and drugs. In cardiac disease treatment, inhibitors like digoxin enhance heart muscle contractility by affecting this pump, demonstrating its significance in both cellular physiology and medical applications.

See more
Open map in editor

1

5

Open map in editor

Want to create maps from your material?

Insert your material in few seconds you will have your Algor Card with maps, summaries, flashcards and quizzes.

Try Algor

Learn with Algor Education flashcards

Click on each Card to learn more about the topic

1

Using energy from ATP hydrolysis, the pump moves three Na+ ions ______ and two K+ ions ______ the cell.

Click to check the answer

out of into

2

The enzyme's cycle includes ______, a shape shift, and ______, setting it up for another ion transport cycle.

Click to check the answer

phosphorylation dephosphorylation

3

Role of cAMP in Na+/K+-ATPase regulation

Click to check the answer

cAMP upregulates Na+/K+-ATPase via Gs-coupled GPCR activation, increasing pump activity.

4

Effect of Gi-coupled GPCRs on Na+/K+-ATPase

Click to check the answer

Gi-coupled GPCRs decrease cAMP levels, leading to downregulation of the sodium-potassium pump.

5

Regulation by 5-InsP7 and IP6K1

Click to check the answer

5-InsP7, produced by IP6K1, promotes endocytosis and degradation of Na+/K+-ATPase, modulating pump activity.

6

______ can increase the expression of Na,K-ATPase mRNA in some cells.

Click to check the answer

Triiodothyronine

7

Cardiac glycosides, like ______ and ______, are used to improve heart performance.

Click to check the answer

digoxin ouabain

8

These medications work by inhibiting the ______ pump, causing a rise in intracellular ______ levels.

Click to check the answer

Na+/K+ Na+

9

The inhibition of the Na+/K+ pump impacts the ______, which depends on the sodium gradient to expel ______ from the cell.

Click to check the answer

Na+/Ca2+ exchanger Ca2+

10

An increase in intracellular ______ levels due to the drugs' action enhances the strength of ______ muscle contractions.

Click to check the answer

Ca2+ cardiac

11

Elevated ______ in heart cells is advantageous in situations requiring increased ______ output.

Click to check the answer

intracellular Ca2+ cardiac

12

Digoxin target enzyme

Click to check the answer

Inhibits Na+/K+-ATPase, especially when phosphorylated.

13

Effect of Na+/K+-ATPase inhibition by digoxin

Click to check the answer

Causes intracellular sodium accumulation, affecting sodium-calcium exchange.

14

Result of increased intracellular calcium from digoxin use

Click to check the answer

Enhances heart muscle contractility, improving cardiac output in heart failure.

15

For his groundbreaking work on the Na+,K+-ATPase enzyme, ______ was honored with the ______ ______ in ______ in ______.

Click to check the answer

Skou Nobel Prize Chemistry 1997

Q&A

Here's a list of frequently asked questions on this topic

Similar Contents

Biology

Evolution of Na/K-ATPase Alpha-Subunit Gene Family in Vertebrates

View document

Biology

The Biological Importance of Sodium Ions

View document

Biology

The Essential Functions of Sodium in the Human Body

View document

Biology

Cellular Transport Mechanisms

View document

The Sodium-Potassium Pump: Essential Cellular Mechanism

The sodium-potassium pump, an essential enzyme found in the plasma membrane of cells, is responsible for maintaining the necessary concentration gradients of sodium (Na+) and potassium (K+) ions. This active transport mechanism uses energy from the hydrolysis of adenosine triphosphate (ATP) to move three Na+ ions out of the cell and two K+ ions into the cell against their respective concentration gradients. The pump operates through a series of steps beginning with the binding of intracellular Na+ ions and ATP, which leads to phosphorylation and a conformational change in the pump. This change reduces the pump's affinity for Na+ ions, releasing them outside the cell, and increases its affinity for K+ ions, which are then bound and transported into the cell. Dephosphorylation of the pump restores its original conformation, completing the cycle and preparing the pump for another round of ion transport.
Cell membrane detail with embedded proteins, phospholipids in shades of pink and folded proteins in blue and green, in aqueous environment.

Endogenous Regulation of the Sodium-Potassium Pump

The sodium-potassium pump's activity is finely tuned by various endogenous factors to meet the cell's physiological demands. Cyclic adenosine monophosphate (cAMP) is one such regulator that can enhance the pump's activity by upregulating the Na+/K+-ATPase enzyme. This occurs through the activation of Gs-coupled G protein-coupled receptors (GPCRs), which increase cAMP levels. In contrast, Gi-coupled GPCRs decrease cAMP and downregulate the pump. The intracellular signaling molecule 5-InsP7, produced by IP6K1, also regulates the pump by promoting its endocytosis and degradation. Additionally, the reversible phosphorylation of the Na+/K+-ATPase is a regulatory mechanism observed in estivating animals, where the pump's activity is reduced during dormancy and restored upon arousal.

Exogenous Influences on the Sodium-Potassium Pump

The function and expression of the sodium-potassium pump can be influenced by exogenous substances, including drugs and hormones. Triiodothyronine, a thyroid hormone, can upregulate the expression of Na,K-ATPase mRNA in certain cells. In cardiac cells, the pump is targeted by cardiac glycosides such as digoxin and ouabain, which are used to enhance cardiac performance by increasing the force of contraction. These drugs inhibit the Na+/K+ pump, leading to an increase in intracellular Na+ levels. This, in turn, affects the Na+/Ca2+ exchanger (NCX), which relies on the Na+ gradient to remove Ca2+ from the cell. The resulting elevation in intracellular Ca2+ levels strengthens cardiac muscle contractions, which is beneficial in conditions where increased cardiac output is required.

Pharmacological Regulation of the Sodium-Potassium Pump in Cardiac Disease

In treating cardiac disease, pharmacological agents such as digoxin are used to inhibit the sodium-potassium pump. Digoxin binds to the Na+/K+-ATPase, particularly when the enzyme is in its phosphorylated state, and impedes its function. This inhibition leads to an accumulation of intracellular sodium, which indirectly causes an increase in intracellular calcium levels via the sodium-calcium exchanger. The increased availability of calcium enhances the contractility of the heart muscle, thereby improving cardiac output in patients with heart failure or other conditions characterized by reduced cardiac efficiency.

Discovery and Recognition of the Sodium-Potassium Pump

The existence of the sodium-potassium pump was first postulated by Jens Christian Skou in 1957 at the University of Aarhus, Denmark. Skou's pioneering research led to the identification of the Na+,K+-ATPase enzyme, a discovery that was published in the same year. In recognition of his significant contribution to our understanding of this vital biological process, which is fundamental to the function of cells and organs, especially in nerve transmission and muscle contraction, Skou was awarded the Nobel Prize in Chemistry in 1997. His work has provided the foundation for much of our current knowledge on cellular ion transport mechanisms.